Tonix’s Bet On Monoclonal Prevention Of Lyme Disease

Pharma Intelligence Podcasts

Lyme disease is spreading, the last US vaccine was withdrawn in 2002, and the most recent attempt at a new one (Pfizer and Valneva's Phase III candidate) missed its primary endpoint earlier this year. Into that gap steps...View more